FDA has approved testing of small quantity of experimental drugs on humans to increase drug discovery and treatment.
Good news for researchers has FDA has approved testing of small quantities of experimental drugs in human beings. Approval of small quantity drug clinical trial will be very helpful for researchers to understand the path of the drug in the body and its efficacy if the drug is proved effective in small quantities researchers can proceed with a phase I clinical trial.
Researchers feel that easing the rules for drug testing will help in drug discovery and opens new options for better treatment. The FDA wants the researchers the ethical rules and informed consent has to be collected for undergoing these trials. This new trial method can also be called as ‘0 phase trial’ as it is the trial involving small quantities of drugs which is in very minimum quantity to produce any adverse action on the health of the patients but, still all precautions with an organized follow up of the patient with the help of a physician should be done. The researchers feel that this phase 0 trial will help to actually evaluate the efficacy of the drug as most of the drugs which was found to be effective in experimental animals were ultimately found to have no therapeutic effect in humans during a clinical trial but this phase 0 trial would help in understanding more effectively the beneficial effect on humans.
